Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

UN Permanent Seat for Germany

The German and British foreign ministers have agreed to hold…
Read more

Israel in China’s Crossfire

The intensifying rivalry between the United States and China…
Read more

Pro-Sovereignty Declaration against EU Overreach

Leaders of European populist and conservative parties have…
Read more